ADX-324

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameADX-324
Drug Alias NameADX-324ADX324
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionPlasma kallikrein inhibitorsRNA interference
TargetsPlasma kallikrein
Therapy Area/IndicationsAngioedemas, Hereditary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[19] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesADARx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesADARx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAngioedemas, Hereditary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A